Oaktree Acquisition Corp. II

OACC

NASDAQFinancial ServicesShell Companies

Open in GoAI

Previous close

$10.78

+$0.04 · +0.37%

Aug 21, 3:59 PM ET

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

60/100

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

Undervalued

Momentum

Weakening

Sentiment

Mixed

Risk resilience

Low Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Industry: Shell Companies
Sector: Financial Services
Headquarters: US
CEO: Zaid Pardesi
Listed since: Dec 16, 2024
Employees: 3

Market position

Day range

Current $10.78

$10.78$10.815

52-week range

Current $10.78

$10.36$10.875

Open: $10.815
Previous close: $10.74
Volume: 15; 0× average
Average volume: 15.26K; Average daily volume
Market cap: 265M USD
Beta: -0.04; Market reference 1
50-day average: $10.7084; +0.67% above average
200-day average: $10.6529; +1.19% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 201.7M USD
P/E (TTM): 38.12×
P/B (TTM): 1.05×
P/S (TTM): 0×
EV / EBITDA: -168.69×
Earnings yield: 3.59%
Free cash flow yield: -0.21%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 0.00%
Operating margin: 0.00%
Net margin: 0.00%
Return on equity: 3.74%
Return on assets: 3.59%
Return on invested capital: -0.59%

Financial health

Debt / equity: 0×
Current ratio: 1.19×
Altman Z-score: 18.1
Piotroski F-score: 3 of 9

Financial statements

Income trends

Operating income

−1.2M USD-169983.50%

Net income

7.29M USD+273607.25%

Metric (USD)	FY2025	FY2024
Selling, general, and administrative	1.2M USD	703.61 USD
Operating expenses	1.2M USD	703.61 USD
Interest income	8.48M USD	1.59M USD
Depreciation and amortization	—	703.61 USD
Operating income	−1.2M USD	−703 USD
Net income	7.29M USD	2.66K USD